• SENSEX 79,454.47
    -880.34 (--1.10%)
  • BANKNIFTY 53,595.25
    -770.40 (--1.42%)
  • TVS Holdings
    8,818.25 7,755.00(%)
  • Angel One
    2,253.00 1,942.00(%)
  • Mazagon Dock
    2,962.90 3,170.00(%)
  • Tata Motors
    710.85 1,179.05(%)
  • Nuvama Wealth
    6,031.50 7,647.95(%)
  • Bharat Dynamics
    1,595.00 1,794.70(%)
  • Yes Bank
    20.36 27.41(%)
  • Bharat Electron
    321.80 340.35(%)
  • Paras Defence
    1,476.00 1,592.75(%)
  • Larsen & Toubro
    3,477.55 3,963.00(%)
  • Cochin Shipyard
    1,491.70 2,977.10(%)
  • Suzlon Energy
    50.96 37.95(%)
  • Jio Financial
    242.15 198.60(%)
  • Apollo Micro Sys
    137.00 157.00(%)
  • Titan Company
    3,530.00 3,866.15(%)
  • Hind.Aeronautics
    4,578.95 5,675.00(%)
  • Reliance Industr
    1,372.05 1,115.55(%)
  • Adani Green
    854.50 758.00(%)
  • Canara Bank
    98.40 129.35(%)
  • Dixon Technolog.
    15,063.05 7,935.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astrazeneca Pharma India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 39.0
  • ISIN : INE203A01020
7,970.50 -213 (-2.60%)
  • As on 11 May 2025 (EOD)

  • Today’s Low

    7,901.00

  • Today’s High

    8,108.00

  • Open

    8,038.00

  • Perv Close

    8,183.00

  • 52W Low

    5,068.60

  • 52W High

    9,211.00

Key Indicators

  • P/E(TTM)

    119.20

  • Mar.Cap (₹Cr.)

    19,926.25

  • Div & Yield %

    0.30

  • Book Value(₹)

    271.74

  • Debt-Equity Ratio

    -2.60

  • AGM Date

    09-May-2025

  • EPS

    67.05

  • P/E Ratio

    119.20

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    19,926.25

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.00

  • BV (₹)

    271.70

  • Sales( ₹ in Cr.)

    1,295.53

  • NP (in Cr.)

    149.06

  • NP Var(%)

    18.0

  • Div%

    1200.0

  • CPS (₹)

    65.60

  • EPS (₹)

    59.60

  • Traded Value (₹ in Lakhs)

    19,980.88

  • 52 Week High

    9,211.00

  • 52 Week Low

    5,068.60

  • Price BSE

    7992.0

  • Price NSE

    7,971.00

  • Market Capital( in Cr.)

    19,980.88

  • P/C Ratio

    121.80

  • P/E Ratio

    134.00

  • Price Vs.BV

    59.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,295.53 1,002.97 805.60 813.56 831.81 728.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,295.53 1,002.97 805.60 813.56 831.81 728.29
Other Income 51.23 26.10 14.76 12.84 12.99 16.29
Stock Adjustments 33.77 48.86 -14.47 -2.95 39.21 1.38
Total Income 1,380.53 1,077.93 805.89 823.45 884.01 745.96
EXPENDITURE :            
Raw Materials 628.33 408.84 297.49 292.00 344.44 232.51
Power and Fuel Cost 4.87 5.54 8.10 7.37 7.72 8.27
Employee Cost 241.45 259.10 230.21 219.54 216.70 197.40
Other Manufacturing Expenses 14.38 13.79 8.05 9.11 9.04 9.83
Selling and Administration Expenses 234.33 185.72 145.09 129.72 157.18 198.14
Miscellaneous Expenses 21.49 53.95 16.01 17.40 15.24 12.22
Employee Benefit Expenses 241.45 259.10 230.21 219.54 216.70 197.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,144.85 926.94 704.95 675.14 750.32 658.37
Operating Profit 235.68 150.99 100.94 148.31 133.69 87.59
Interest 1.20 0.63 0.95 1.09 1.14 0.00
Gross Profit 234.48 150.36 99.99 147.22 132.55 87.59
Depreciation 14.94 16.26 16.95 20.13 18.58 14.92
Profit Before Tax 219.54 134.10 83.04 127.09 113.97 72.67
Current Tax 58.93 38.30 22.63 34.83 31.51 16.68
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.90 -3.49 -1.19 -1.04 10.25 1.54
Reported Net Profit 161.51 99.29 61.60 93.30 72.21 54.45
Extraordinary Items 12.45 -26.96 2.05 1.58 0.18 0.04
Adjusted Net Profit 149.06 126.25 59.55 91.72 72.03 54.41
Adjustment below Net Profit 1.00 -2.61 -1.74 3.43 -5.56 -0.60
P & L Balance brought forward 455.64 378.96 324.10 232.37 168.22 114.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 40.00 20.00 5.00 5.00 2.50 0.00
P & L Balance carried down 578.15 455.64 378.96 324.10 232.37 168.22
Dividend 0.00 0.00 5.00 5.00 2.50 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,200.00 800.00 500.00 100.00 50.00 0.00
Dividend Per Share(Rs) 24.00 16.00 10.00 2.00 1.00 0.00
Earnings Per Share-Unit Curr 64.60 39.72 24.64 37.32 28.88 21.78
Earnings Per Share(Adj)-Unit Curr 64.60 39.72 24.64 37.32 28.88 21.78
Book Value 284.77 235.48 204.56 182.47 145.78 120.32
Book Value(Adj)-Unit Curr 284.77 235.48 204.56 182.47 145.78 120.32

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 18,750,000 75.00 18,750,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18,750,000 75.00 18,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 721,326 2.89 721,326 95
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 41,056 0.16 41,056 9
Mutual Funds / UTI 1,111,255 4.45 1,111,255 53
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,022 0.04 10,022 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,884,034 7.54 1,883,909 164
2] Non Institution
Bodies Corporate 340,673 1.36 340,673 250
Clearing Members 121 0.00 121 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 97,930 0.39 97,430 1,139
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,666,112 6.66 1,666,112 7
Individuals holding nominal share capital up to Rs. 1 lakh 2,123,147 8.49 1,999,192 30,896
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 10,131 0.04 10,131 5
Others 102,182 0.41 102,182 1
Sub Total 4,365,966 17.46 4,241,511 32,301
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 24,875,420 32,466

Company Background

Astrazeneca Pharma India LtdPharmaceuticals - Multinational

  • Astrazeneca Pharma India Ltd
  • BSE Code : 39.0
  • ISIN : INE203A01020

  • Incorporation Year

    1979

  • Registered Office

    Blk N1 12th Flr Manyata Embass
    Rachenahalli Outer Ring Road, Bangalore,
    Karnataka-560045

  • Telephone

    91-080-67748000

  • FAX

    91-080-67748557

  • Chairman

    Narayan K Seshadri

  • Managing Director

    Sanjeev Panchal

  • Company Secretary

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Enterprises (I) Ltd
    No. 30 Ramana Resid.,
    4th Cross Sampige Rd,Malleswaram
    Mumbai - Bangalore - 560003

Astrazeneca Pharma India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astrazeneca Phar 7,992.35 1,330.33 1,295.53 206.04 33.26
Abbott India 30,147.65 6,097.18 5,848.91 48.01 44.71
P & G Health Ltd 5,030.35 1,166.89 1,151.26 35.30 39.76
Glaxosmi. Pharma 2,758.30 3,530.73 3,407.25 54.85 44.44
Cipla 1,478.50 17,645.00 16,574.34 25.35 20.10
Novartis India 804.10 396.75 335.07 23.01 15.57
Amrutanjan Healt 692.60 437.58 421.23 40.60 20.84
Guj. Themis Bio. 269.15 174.19 169.82 55.72 44.82
Fermenta Biotec. 258.90 315.24 307.09 24.54 4.10
Bliss GVS Pharma 112.05 638.96 605.46 25.64 11.19
Ambalal Sarabhai 35.20 11.70 3.81 15.04 1.92